<DOC>
	<DOCNO>NCT02858128</DOCNO>
	<brief_summary>The purpose study determine effectiveness whole-body diffusion-weighted magnetic resonance imaging ( WB-DW- MRI ) detect metastasis compare result choline-positron emission tomography-computed tomography ( choline-PET/CT ) patient metastatic/oligometastatic prostate cancer . Patients disease profile could benefit treatment stereotactic body radiation therapy ( SBRT ) select response technique rat .</brief_summary>
	<brief_title>WB-DW-MRI v CHOLINE-PET/CT Selecting Treatments Recurrent Prostate Cancer</brief_title>
	<detailed_description>This prospective , control , unicentric study , involve 46 consecutive patient centre present biochemical relapse adjuvant , salvage radical treatment external beam radiotherapy , brachytherapy . After initial test ( bone scintigraphy , CT , pelvic MRI ) 35 patient oligometastases without select . 11 patient multiple metastasis exclude study . WB-DW- MRI choline-PET/CT perform patient within one week . The result interpret specialist nuclear medicine MRI . If candidate treatment ablative SBRT ( SABR ) evaluate every three month test .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Prostate cancer histologic diagnostic one treatment 5 less lessions Asimptomatic lessions Informed Consent Form sign Not capability perform NMR o CT/PET scan</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>